Short and sweet...Best financials in the whole MJ/CBD industry. Any dilution going forward will come with massive amounts of CASH into the coffers... BUKKO $$$$$$$$. Increasing TOTAL EQUITY and BOOK VALUE tremendously by several multiples.
The company was operating with less than $2M of cash & short term equiv. just a year ago. Is generating $4M of CASH per quarter NOW. CVSI can easily operate with it's current cash available for the next 3 years. At some point next year the SP will be high enough to get the coffers filled with minimum dilution, which will secure enough CASH to expand 12+ fold (at least when necessary) or buy a small specialized MJ company to expand into other MJ compounds once the medical MJ becomes legal. Or both. CVSI is securing a well developed distribution channel. I'm sure management has to consider expanding into other compounds to enhance the brand and develop new ones. And small MJ companies NOT doing so well are plenty.
TTM Total sales = $41.26M from $16.65M a year ago. Or 148% Year/Year TTM. TTM Cash from operations = $12.9M or 31.3% of T Sales. TTM FCF = $12.1M or 29.4% of T Sales.
It is very possible that CVSI will surpass the $100M in sales next year FY2019 with the current trends. But the FB passing into law will practically guarantee this. Don't forget the 30+% FCF rate.
News 
Market Data 
Discover 
AI
